Amsurg Corp. (AMSG) Stock Price Up 4.7%
Amsurg Corp. (NASDAQ:AMSG)’s share price rose 4.7% during trading on Thursday . The company traded as high as $65.65 and last traded at $65.57, with a volume of 993,750 shares. The stock had previously closed at $62.60.
AMSG has been the subject of a number of recent analyst reports. Jefferies Group reaffirmed a “buy” rating on shares of Amsurg Corp. in a research note on Sunday, July 3rd. Robert W. Baird reiterated a “buy” rating on shares of Amsurg Corp. in a report on Thursday, June 16th. Zacks Investment Research upgraded shares of Amsurg Corp. from a “hold” rating to a “buy” rating and set a $88.00 price objective for the company in a report on Monday, July 11th. Mizuho lifted their price objective on shares of Amsurg Corp. from $84.00 to $90.00 and gave the company a “buy” rating in a report on Wednesday, May 4th. Finally, Goldman Sachs Group Inc. reiterated a “buy” rating on shares of Amsurg Corp. in a report on Friday, June 17th. Four equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $93.91.
The firm has a market capitalization of $3.47 billion and a price-to-earnings ratio of 19.18. The company’s 50 day moving average is $73.44 and its 200-day moving average is $74.17.
Amsurg Corp. (NASDAQ:AMSG) last announced its quarterly earnings data on Tuesday, August 2nd. The company reported $1.10 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.08 by $0.02. The firm earned $758.50 million during the quarter, compared to analysts’ expectations of $769.88 million. The company’s revenue for the quarter was up 21.5% compared to the same quarter last year. During the same period in the prior year, the company posted $0.97 EPS. Equities research analysts expect that Amsurg Corp. will post $4.33 earnings per share for the current year.
Several large investors have recently made changes to their positions in the stock. Redwood Investments LLC raised its stake in shares of Amsurg Corp. by 20.3% in the fourth quarter. Redwood Investments LLC now owns 28,011 shares of the company’s stock worth $2,129,000 after buying an additional 4,732 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in shares of Amsurg Corp. by 3.2% in the fourth quarter. Dimensional Fund Advisors LP now owns 2,994,029 shares of the company’s stock worth $227,552,000 after buying an additional 92,088 shares in the last quarter. US Bancorp DE raised its stake in shares of Amsurg Corp. by 30.5% in the fourth quarter. US Bancorp DE now owns 23,339 shares of the company’s stock worth $1,774,000 after buying an additional 5,461 shares in the last quarter. Morgan Stanley raised its stake in shares of Amsurg Corp. by 115.7% in the fourth quarter. Morgan Stanley now owns 182,105 shares of the company’s stock worth $13,840,000 after buying an additional 97,682 shares in the last quarter. Finally, BNP Paribas Arbitrage SA raised its stake in shares of Amsurg Corp. by 1,872.0% in the fourth quarter. BNP Paribas Arbitrage SA now owns 194,790 shares of the company’s stock worth $14,804,000 after buying an additional 184,912 shares in the last quarter.
AmSurg Corp. is a surgical center and physician services company. The Company is an owner and operator of ambulatory surgery centers (ASCs) in the United States. The Company is also a provider of outsourced physician services in the areas of anesthesiology, children’s services, emergency medicine and radiology.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.